• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

619例成年急性髓系白血病患者缓解诱导期影响预后的特征

Features affecting outcome during remission induction of acute myeloid leukaemia in 619 adult patients.

作者信息

Swirsky D M, de Bastos M, Parish S E, Rees J K, Hayhoe F G

出版信息

Br J Haematol. 1986 Nov;64(3):435-53. doi: 10.1111/j.1365-2141.1986.tb02200.x.

DOI:10.1111/j.1365-2141.1986.tb02200.x
PMID:3466640
Abstract

Six hundred and nineteen patients with de novo acute myeloid leukaemia, entered into the Medical Research Council's eighth trial of therapy have been studied. All patients were treated with the same remission induction regimen. Pretreatment variables comprising age, clinical status, haematological status and a detailed marrow cytology and cytochemistry score have been analysed. Poorer remission rates have been found in older patients, in those with lower Karnofsky scores and in patients with a platelet count of less than 25 X 10(9)/l. Leukaemias showing evidence of cytoplasmic maturation along the granulocyte and monocyte lines, as evidenced by granules, Auer rods, a high percentage of Sudan black positive blast cells and morphological and cytochemical abnormalities of neutrophils were associated with a higher remission rate. Marrow eosinophilia was a good prognostic feature. Nuclear features of immaturity, i.e. increasing numbers and prominence of nucleoli were associated with a low remission rate. Abnormalities of the erythroid series, notably Periodic acid-Schiff positivity which was present in 133 cases (22% of the total), was associated with a low remission rate. Patient age and pretreatment Karnofsky score were the most useful predictors of treatment outcome.

摘要

对参加医学研究委员会第八次治疗试验的619例初发急性髓系白血病患者进行了研究。所有患者均采用相同的缓解诱导方案进行治疗。对包括年龄、临床状态、血液学状态以及详细的骨髓细胞学和细胞化学评分在内的预处理变量进行了分析。研究发现,年龄较大、卡诺夫斯基评分较低以及血小板计数低于25×10⁹/L的患者缓解率较低。白血病沿粒细胞和单核细胞系显示出细胞质成熟的证据,如颗粒、奥氏小体、高比例的苏丹黑阳性原始细胞以及中性粒细胞的形态和细胞化学异常,这些与较高的缓解率相关。骨髓嗜酸性粒细胞增多是一个良好的预后特征。核不成熟特征,即核仁数量增加和突出,与低缓解率相关。红系异常,尤其是133例(占总数的22%)出现的过碘酸-希夫阳性,与低缓解率相关。患者年龄和预处理卡诺夫斯基评分是治疗结果最有用的预测指标。

相似文献

1
Features affecting outcome during remission induction of acute myeloid leukaemia in 619 adult patients.619例成年急性髓系白血病患者缓解诱导期影响预后的特征
Br J Haematol. 1986 Nov;64(3):435-53. doi: 10.1111/j.1365-2141.1986.tb02200.x.
2
Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1,386 patients with de novo acute myeloid leukaemia.苏丹黑阳性的预后重要性:对1386例初发急性髓系白血病患者骨髓涂片的研究
Br J Haematol. 1991 Nov;79(3):398-407. doi: 10.1111/j.1365-2141.1991.tb08047.x.
3
[Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83].[AML-BFM-78和-83研究中急性髓系白血病患儿奥氏小体的发生率及预后意义]
Klin Padiatr. 1989 Jul-Aug;201(4):227-32. doi: 10.1055/s-2007-1025308.
4
Auer bodies in acute myeloid leukaemia patients.急性髓系白血病患者的奥氏小体
Pathol Res Pract. 1990 Apr;186(2):293-5. doi: 10.1016/S0344-0338(11)80547-9.
5
8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features.急性粒细胞白血病中的8;21易位:细胞学、细胞化学及临床特征
Br J Haematol. 1984 Feb;56(2):199-213. doi: 10.1111/j.1365-2141.1984.tb03948.x.
6
Cytochemistry of the acute leukaemias.
Histochem J. 1984 Oct;16(10):1051-9. doi: 10.1007/BF01002894.
7
[Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].[儿童急性白血病中表达非典型免疫表型的分化细胞的生物学特性及对诱导治疗的敏感性]
Folia Med Cracov. 2001;42(3):5-80.
8
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.60 岁或以上急性髓系白血病患者接受强化化疗后的完全缓解和早期死亡:一种用于预测结局的网络应用。
Lancet. 2010 Dec 11;376(9757):2000-8. doi: 10.1016/S0140-6736(10)62105-8. Epub 2010 Dec 3.
9
Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -83.奥厄小体在儿童急性髓细胞白血病中的预后意义:AML-BFM-78和-83研究结果
Med Pediatr Oncol. 1989;17(3):202-9. doi: 10.1002/mpo.2950170307.
10
Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.医学研究委员会第八次急性髓细胞白血病试验的主要结果。
Lancet. 1986 Nov 29;2(8518):1236-41. doi: 10.1016/s0140-6736(86)92674-7.

引用本文的文献

1
MRD in Acute Leukemias: Lessons Learned from Acute Promyelocytic Leukemia.急性白血病中的微小残留病:从急性早幼粒细胞白血病中汲取的经验教训。
Cancers (Basel). 2024 Sep 20;16(18):3208. doi: 10.3390/cancers16183208.
2
Acute myeloid leukaemia: optimal management and recent developments.急性髓系白血病:最佳管理和最新进展。
Drugs. 2011 Aug 20;71(12):1537-50. doi: 10.2165/11593060-000000000-00000.
3
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation.
NCI 首届同种异体造血干细胞移植后复发的生物学、预防和治疗国际研讨会:来自异体细胞移植后复发的流行病学和自然史委员会的报告。
Biol Blood Marrow Transplant. 2010 Jul;16(7):871-90. doi: 10.1016/j.bbmt.2010.04.004. Epub 2010 Apr 24.
4
Colony-stimulating factors in the treatment of older patients with acute myelogenous leukaemia.集落刺激因子在老年急性髓系白血病患者治疗中的应用
Drugs Aging. 1999 Dec;15(6):451-60. doi: 10.2165/00002512-199915060-00005.
5
Prognostic importance of retinopathy in acute leukemia.视网膜病变在急性白血病中的预后重要性。
Doc Ophthalmol. 1995;91(3):273-81. doi: 10.1007/BF01204178.
6
Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukemia in older patients.米托蒽醌和阿糖胞苷用于老年患者急性髓细胞白血病的治疗。
Ann Hematol. 1995 Jul;71(1):35-9. doi: 10.1007/BF01696230.
7
Routine immunophenotyping of acute leukaemias.
Blut. 1988 Dec;57(6):327-39. doi: 10.1007/BF00320752.
8
Acute myeloid leukemia in the elderly: biological features and search for adequate treatment.老年急性髓系白血病:生物学特征及合适治疗方法的探索
Ann Hematol. 1991 Oct;63(4):179-88. doi: 10.1007/BF01703440.
9
High-dose cytosine arabinoside intensification for acute nonlymphocytic leukemia in patients over 56 years of age.
Ann Hematol. 1992 Apr;64(4):185-9. doi: 10.1007/BF01696221.
10
Age and the biology of acute myeloid leukemia.年龄与急性髓系白血病生物学
Ann Hematol. 1992 Mar;64(3):157-9. doi: 10.1007/BF01697405.